Top Tweets for #Cstone
According to documents disclosed by #HKSE, on August 18, the Government of Singapore Investment Corporation (GIC), a sovereign wealth fund, increased its stake in 🇨🇳 #CStone, a biotech listed on the HKEX 18A sector, by acquiring a total of 80.4 million ordinary shares at an average price of HK$7.9 per share, with a total value of approximately HK$635 million. Following this acquisition, GIC's shareholding in CStone rose from 0.00% to 5.49%.
Fantastic to meet Yucheng Sheng again in Shanghai during my transit. This was 2nd time meeting him after our time at @School_Pharmacy! He is now a Senior Director in #CSTONE Pharmaceutical! Great to know his success in industry & his endless passion in #pharmaceuticalscience!
🇨🇳 #CStone Pharmaceuticals announced an exclusive partnership with Istituto Gentili, a leading European biopharmaceutical company with a century-long heritage in oncology, to commercialize #sugemalimab across Western Europe and the UK. https://t.co/o1ITRPi2MV
Gentili will receive exclusive commercialization rights for sugemalimab in 23 European countries.
CStone is eligible to receive up to US$192.5 million in total consideration, comprising an upfront payment and payments tied to regulatory and commercial milestones. Additionally, CStone will supply sugemalimab and recognize close to 50% of net sales from the licensed territories as revenue, while Gentili will lead all local regulatory and commercial operations in the covered regions.
🇨🇳 #CStone Pharma announced today that the global multicenter Phase I/II study of #CS2009, a potential first-in-class/best-in-class PD-1/VEGF/CTLA-4 #trispecific #antibody independently developed by CStone, is actively enrolling patients in Australia and China, with planned expansion to the United States for Phase II enrollment. https://t.co/0D7auwpypq
Recently, a PCT patent of 🇨🇳 #Zelgen's PD-L1/VEGF/CCR8 trispecific antibody (WO2025140619).
To date, 4 PD-1(L1)/VEGF trispecific antibody drugs have entered clinical trials, including 2 PD-1/VEGF/CTLA-4 antibodies and 2 PD-L1/VEGF/TGFβ antibodies. (Source: UmabsDB)
PD-1/VEGF/CTLA-4:
-HC 010 (🇨🇳 HC Biopharma, Ph1)
-CS 2009 (🇨🇳 CStone, Ph1)
-GB 268 (🇨🇳Genor Biopharma, IND submission)
PD-L1/VEGF/TGFβ
-PM8003 (🇨🇳 Biotheus, Ph1 discontinued)
-DR30206 (🇨🇳 Doer Biologics, Ph1)
-Q 1806 (🇨🇳 QureBio, Preclinical)
PD-L1/VEGF/HER2
-(🇨🇳 Sanyou Bio, patent public)
PD-L1/VEGF/CCR8
-(🇨🇳 Zelgen, patent public)
1/2
想要1魚多吃的朋友，現在手續費下降了，適合小資族 ~
本次以質押在 #Zircuit 為例(未發幣)：
step1
先去 #stakestone 網站去claim #cSTONE (手續費7.5U)
step2
再去zircuit網站(https://t.co/5q4LcKaD5q)去Stake cSTONE
這裡同時如果有pufETH的朋友可以一起質押
CStone to present the latest clinical results of anti-PD-L1 antibody Sugemalimab at ASCO 2022.
#cstone #medical #Sugemalimab #ASCO #biopharmaceutical #health #healthcare #antibody #therapies #research #development #cstonepharmaceuticals
https://t.co/FXPDyMYGzJ
https://t.co/RPVQyithn6
#世界肺癌大会亮点一文总结：安进、阿斯利康、罗氏、和黄医药、基石药业等公布最新结果
Highlights of the #WorldLungCancerConference Summary: #Amgen, #AstraZeneca, #Roche, #Chi-Med, #CStone, etc. announce the latest results
#WCLC2022
NSCLSの一次治療において、#Cstone 社/#EQRX 社 #sugemalimab と #Shanghai Junshi社/#Coherus 社 #toripalimabは承認可能な抗PD-(L)1プロジェクトを持っているかもしれないが、価格面で #Merck 社の #Keytruda に対抗できるかが鍵だ。
https://t.co/ZlJeImRRqn
#Evaluate
#CStone announces clinical data of #sugemalimab in patients with stage III non-small cell lung #cancer selected as late-breaking abstract for oral presentation at ESMO Congress 2021; #OmniAb https://t.co/pH0EoHBRtD
CStone Enters $1 Billion Deal with EQRx to Advance Immunotherapy Agents
#biospace #lifesciences #biotechnology #pharmaceuticals #CStone #immunotherapy
https://t.co/rXmkyIEsj9
Demiurge AI-based #clinicaltrials outcome predictions made on February 05 2020 put to the public test (028_2020):
SUCCESS for
#spartalizumab / NCT03728556 / #CStone
@GICGroup @Fidelity @TRowePrice
Big moves in Management Tracks in @BioCentury today. @SusanDesmondH15 ; #CStone nabs ex @bmsnews exec; @JanssenUS gets @US_FDA alum, and more.https://t.co/jb4pyI3f5r
#WeeklyinAsia 2019｜JULY
1/ The 21st #INTERPHEX Week Japan 2019 Concludes on a Successful Note
2/ #CStone Announces Global Collaboration with @BayerPharma on Combination Therapy for Cancer
3/ @MacroGenics and #IMab..........
https://t.co/lBnQCbpY9k
Last Seen Hashtags on Sotwe
soles
Seen from Turkey
แม่ลูกเอากัน
Seen from Japan
RashmikaMandanna
Seen from India
fuckmachine gay
Seen from Netherlands
裸舞
Seen from Germany
Teenage nolimit *
Seen from Turkey
Lillycat
Seen from Turkey
shenaztreasury
Seen from India
媚黑
Seen from India
nolimit(*)** +filter:native_video
Seen from Austria
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111.1M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.9M followers
Taylor Swift
@taylorswift13
81.8M followers
Lady Gaga
@ladygaga
73.3M followers
Virat Kohli
@imvkohli
70.3M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
63.1M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61M followers
X
@x
60.8M followers